2012 Fiscal Year Final Research Report
Elucidation of energy metabolic pathways in hormone-dependent cancers by utilizing cellular and in vivo imaging analyses
Project/Area Number |
23659479
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Endocrinology
|
Research Institution | Saitama Medical University |
Principal Investigator |
HORIE Kuniko 埼玉医科大学, 医学部, 准教授 (90261982)
|
Co-Investigator(Kenkyū-buntansha) |
IKEDA Kazuhiro 埼玉医科大学, 医学部, 講師 (30343461)
|
Co-Investigator(Renkei-kenkyūsha) |
INOUE Satoshi 東京大学, 医学部, 特任教授 (40251251)
|
Project Period (FY) |
2011 – 2012
|
Keywords | 性ホルモン / がん / イメージング / エネルギー代謝 |
Research Abstract |
In order to reveal characterize metabolic pathways involved in the proliferation and progression of hormone-dependent cancers such as breast and prostate cancers, cell models of hormone-naive and hormone-resistant cancer cellsexpressing fluorescent reporters were generated. A microscopic imaging system for the observation of these cancer cells was developed in response to environmental alterationsby monitoring reporter fluorescence. Inoculation of cancer cells stably expressing luciferase reporter genes into nude mice was performed and the dynamics of cancer cell proliferation and metastasis were investigated based on in vivo imaging analysis. Expression and transcriptional regulation of metabolic genes in hormone-dependent cancer cells were analyzed molecular biologically. Taken together, the present study identified novel molecular targets that can be applied to the diagnosis, therapy, and prevention of hormone-dependent cancers.
|
-
-
[Journal Article] Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients.2012
Author(s)
Ijichi N, Shigekawa T, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S.
-
Journal Title
Horm Cancer
Volume: 3(4)
Pages: 147-159
DOI
Peer Reviewed
-
-
-
[Journal Article] FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer2011
Author(s)
Shigekawa T, Ijichi N, Ikeda K, Horie-Inoue K, Shimizu C, Saji S, Aogi K, Tsuda H, Osaki A, Saeki T, Inoue S
-
Journal Title
Horm Cancer
Volume: 2(5)
Pages: 286-297.
DOI
Peer Reviewed
-
-
-
-